Literature DB >> 23233677

Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein.

Alan Basset1, Fan Zhang, Cyril Benes, Sabina Sayeed, Muriel Herd, Claudette Thompson, Douglas T Golenbock, Andrew Camilli, Richard Malley.   

Abstract

The pneumococcal type 1 pilus is an inflammatory and adherence-promoting structure associated with increased virulence in mouse models. We show that RrgA, an ancillary pilus subunit devoid of a lipidation motif, particularly when presented as part of an oligomer, is a TLR2 agonist. The surface-exposed domain III, and in particular a 49-amino acid sequence (P3), of the protein is responsible for the TLR2 activity of RrgA. A pneumococcal mutant carrying RrgA with a deletion of the P3 region was significantly reduced in its ability to activate TLR2 and induce TNF-α responses after mouse intraperitoneal infection, whereas no such difference could be noted when TLR2(-/-) mice were challenged, further implicating this region in recognition by TLR2. Thus, we conclude that the type 1 pneumococcal pilus can activate cells via TLR2, and the ancillary pilus subunit RrgA is a key component of this activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233677      PMCID: PMC3554933          DOI: 10.1074/jbc.M112.398875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes.

Authors:  M Lipsitch
Journal:  Am J Epidemiol       Date:  2001-07-01       Impact factor: 4.897

Review 2.  TLR2: cellular sensor for microbial and endogenous molecular patterns.

Authors:  C J Kirschning; R R Schumann
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.

Authors:  D E Briles; S Hollingshead; A Brooks-Walter; G S Nabors; L Ferguson; M Schilling; S Gravenstein; P Braun; J King; A Swift
Journal:  Vaccine       Date:  2000-02-25       Impact factor: 3.641

4.  Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Authors:  S B Black; H R Shinefield; J Hansen; L Elvin; D Laufer; F Malinoski
Journal:  Pediatr Infect Dis J       Date:  2001-12       Impact factor: 2.129

5.  Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Authors:  Priya Balachandran; Alexis Brooks-Walter; Anni Virolainen-Julkunen; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.

Authors:  O Takeuchi; K Hoshino; S Akira
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

7.  An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae.

Authors:  C K Sung; H Li; J P Claverys; D A Morrison
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

8.  Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.

Authors:  A D Ogunniyi; R L Folland; D E Briles; S K Hollingshead; J C Paton
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.

Authors:  Philipp Henneke; Osamu Takeuchi; Richard Malley; Egil Lien; Robin R Ingalls; Mason W Freeman; Tanya Mayadas; Victor Nizet; Shizuo Akira; Dennis L Kasper; Douglas T Golenbock
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

10.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

View more
  23 in total

1.  Stevioside plays an anti-inflammatory role by regulating the NF-κB and MAPK pathways in S. aureus-infected mouse mammary glands.

Authors:  Tiancheng Wang; Mengyao Guo; Xiaojing Song; Zecai Zhang; Haichao Jiang; Wei Wang; Yunhe Fu; Yongguo Cao; Lianqin Zhu; Naisheng Zhang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

2.  Purified Streptococcus pneumoniae Endopeptidase O (PepO) Enhances Particle Uptake by Macrophages in a Toll-Like Receptor 2- and miR-155-Dependent Manner.

Authors:  Hua Yao; Hong Zhang; Kai Lan; Hong Wang; Yufeng Su; Dagen Li; Zhixin Song; Fang Cui; Yibing Yin; Xuemei Zhang
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

3.  The Pneumococcal Type 1 Pilus Genes Are Thermoregulated and Are Repressed by a Member of the Snf2 Protein Family.

Authors:  Alan Basset; Muriel Herd; Raecliffe Daly; Simon L Dove; Richard Malley
Journal:  J Bacteriol       Date:  2017-07-11       Impact factor: 3.490

4.  Polydatin ameliorates Staphylococcus aureus-induced mastitis in mice via inhibiting TLR2-mediated activation of the p38 MAPK/NF-κB pathway.

Authors:  Kang-Feng Jiang; Gan Zhao; Gan-Zhen Deng; Hai-Chong Wu; Nan-Nan Yin; Xiu-Ying Chen; Chang-Wei Qiu; Xiu-Li Peng
Journal:  Acta Pharmacol Sin       Date:  2016-11-28       Impact factor: 6.150

5.  The role of pili in Bacillus cereus intraocular infection.

Authors:  Michelle C Callegan; Salai Madhumathi Parkunan; C Blake Randall; Phillip S Coburn; Frederick C Miller; Austin L LaGrow; Roger A Astley; Craig Land; So-Young Oh; Olaf Schneewind
Journal:  Exp Eye Res       Date:  2017-03-20       Impact factor: 3.467

6.  Piliation of Lactobacillus rhamnosus GG promotes adhesion, phagocytosis, and cytokine modulation in macrophages.

Authors:  Cynthia E Vargas García; Mariya Petrova; Ingmar J J Claes; Ilke De Boeck; Tine L A Verhoeven; Ellen Dilissen; Ingemar von Ossowski; Airi Palva; Dominique M Bullens; Jos Vanderleyden; Sarah Lebeer
Journal:  Appl Environ Microbiol       Date:  2015-01-09       Impact factor: 4.792

7.  A Serine-Threonine Kinase (StkP) Regulates Expression of the Pneumococcal Pilus and Modulates Bacterial Adherence to Human Epithelial and Endothelial Cells In Vitro.

Authors:  Jenny A Herbert; Andrea M Mitchell; Timothy J Mitchell
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 8.  Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.

Authors:  Helen C Steel; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2013-12-25       Impact factor: 4.711

9.  Using recombinant Lactococci as an approach to dissect the immunomodulating capacity of surface piliation in probiotic Lactobacillus rhamnosus GG.

Authors:  Ingemar von Ossowski; Taija E Pietilä; Johanna Rintahaka; Elina Nummenmaa; Veli-Matti Mäkinen; Justus Reunanen; Reetta Satokari; Willem M de Vos; Ilkka Palva; Airi Palva
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

10.  Human Gut-Commensalic Lactobacillus ruminis ATCC 25644 Displays Sortase-Assembled Surface Piliation: Phenotypic Characterization of Its Fimbrial Operon through In Silico Predictive Analysis and Recombinant Expression in Lactococcus lactis.

Authors:  Xia Yu; Annukka Jaatinen; Johanna Rintahaka; Ulla Hynönen; Outi Lyytinen; Ravi Kant; Silja Åvall-Jääskeläinen; Ingemar von Ossowski; Airi Palva
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.